Monika Siolek

Kielce, SK, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Updated ENIGMA recommendations for reporting germline variants in cancer susceptibility genes and their translation into twenty languages.

Updated ENIGMA recommendations for reporting germline variants in cancer susceptibility genes and their translation into twenty languages.

Journal: Journal of medical genetics

Published: January 13, 2026

Blood molybdenum level as a marker of cancer risk on BRCA1 carriers.

Blood molybdenum level as a marker of cancer risk on BRCA1 carriers.

Journal: Hereditary cancer in clinical practice

Published: August 01, 2024

Antioxidant Properties of Zinc and Copper-Blood Zinc-to Copper-Ratio as a Marker of Cancer Risk BRCA1 Mutation Carriers.

Antioxidant Properties of Zinc and Copper-Blood Zinc-to Copper-Ratio as a Marker of Cancer Risk BRCA1 Mutation Carriers.

Journal: Antioxidants (Basel, Switzerland)

Published: June 05, 2024

Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 Carriers.

Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 Carriers.

Journal: Nutrients

Published: March 26, 2024

Blood Iodine as a Potential Marker of the Risk of Cancer in BRCA1 Carriers.

Blood Iodine as a Potential Marker of the Risk of Cancer in BRCA1 Carriers.

Journal: Nutrients

Published: March 23, 2024

Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers.

Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers.

Journal: Antioxidants (Basel, Switzerland)

Published: March 23, 2024

Relationship between the Expression of CHK2 and p53 in Tumor Tissue and the Course of Papillary Thyroid Cancer in Patients with CHEK2 Germline Mutations.

Relationship between the Expression of CHK2 and p53 in Tumor Tissue and the Course of Papillary Thyroid Cancer in Patients with CHEK2 Germline Mutations.

Journal: Cancers

Published: December 28, 2023

The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations.

The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations.

Journal: British journal of cancer

Published: September 22, 2021

Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma.

Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma.

Journal: Cancers

Published: December 19, 2020

Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course.

Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course.

Journal: Cancers

Published: October 11, 2019

Somatic mutations in BRCA1&2 in 201 unselected ovarian carcinoma samples - single institution study.

Somatic mutations in BRCA1&2 in 201 unselected ovarian carcinoma samples - single institution study.

Journal: Polish journal of pathology : official journal of the Polish Society of Pathologists

Published: September 27, 2019

A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy.

A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy.

Journal: Gynecologic oncology

Published: March 25, 2019

Showing 1-12 of 23

Last Updated: 09/26/2026